ARCHIVES

Phase II Study Finds Dasatinib May Overcome ALL Resistance

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

Some Tumors Show Partial Response To Drug Combo

January 27, 2006

In Brief: Holleb Named Memorial Distinguished Alumnus; Hankey Appointed DCPC Statistics Branch Chief

September 1, 1989

Dana-Farber Picks Rosenthal To Direct New Center For Integrated Therapies.

June 23, 2000

Breast Cancer Coalition to Congress: ‘Find a Way To Fund The War,’ Bypass Level Is Not Enough

August 7, 1992

Carlson Named NCCN Chief Executive

September 28, 2012

NCI Plans $30 Million In Patient-Oriented Chemoprevention research In Next 5 Years

December 6, 1996